XML 39 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Investments and fair value measurements (Tables)
9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Summary of Investments on Condensed Consolidated Balance Sheets
The Company’s assets and liabilities that are measured at fair value on a recurring or nonrecurring basis within the fair value hierarchy are as follows (in thousands):

As of September 30, 2023
Level 1Level 2Level 3
Cash equivalents:
Money market funds$267,036 $— $— 
U.S. government securities— 14,881 — 
Total cash equivalents267,036 14,881 — 
Marketable securities:
U.S. government securities$— $151,466 $— 
Non-current assets:
Strategic investments$— $— $10,311 
Non-current liabilities:
Cash settled stock appreciation rights$— $— $26 

As of December 31, 2022
Level 1Level 2Level 3
Cash equivalents:
Money market funds$130,377 $— $— 
U.S. government securities— 48,900 — 
Total cash equivalents$130,377 $48,900 $— 
Marketable securities:
U.S. government securities$— $151,687 $— 
Non-current assets:
Strategic investments$— $— $12,104 
Non-current liabilities:
Cash settled stock appreciation rights$— $— $462 
Summary of Investments on Condensed Consolidated Balance Sheets
The Company’s assets and liabilities that are measured at fair value on a recurring or nonrecurring basis within the fair value hierarchy are as follows (in thousands):

As of September 30, 2023
Level 1Level 2Level 3
Cash equivalents:
Money market funds$267,036 $— $— 
U.S. government securities— 14,881 — 
Total cash equivalents267,036 14,881 — 
Marketable securities:
U.S. government securities$— $151,466 $— 
Non-current assets:
Strategic investments$— $— $10,311 
Non-current liabilities:
Cash settled stock appreciation rights$— $— $26 

As of December 31, 2022
Level 1Level 2Level 3
Cash equivalents:
Money market funds$130,377 $— $— 
U.S. government securities— 48,900 — 
Total cash equivalents$130,377 $48,900 $— 
Marketable securities:
U.S. government securities$— $151,687 $— 
Non-current assets:
Strategic investments$— $— $12,104 
Non-current liabilities:
Cash settled stock appreciation rights$— $— $462 
Summary of the Changes in the Fair Value of Level 3 Financial Instruments
A summary of the changes in the fair value of Level 3 financial instruments, of which remeasurement of SARs and impairment of strategic investments are recognized in the condensed consolidated statements of operations, is as follows (in thousands):

Stock Appreciation RightsStrategic Investments
Balance— June 30, 2023
$30 $10,311 
Vesting and remeasurement of SARs(4)— 
Balance— September 30, 2023
$26 $10,311 
Balance— June 30, 2022
$419 $15,000 
Vesting and remeasurement of SARs, net of exercises165 — 
Amount reclassified from liability to equity upon exchange(62)— 
Unrealized loss on strategic investments— (2,896)
Balance— September 30, 2022
$522 $12,104 
Balance— December 31, 2022
$462 $12,104 
Vesting and remeasurement of SARs(183)— 
Exercises of SARs(253)— 
Unrealized loss on strategic investments— (1,793)
Balance— September 30, 2023
$26 $10,311 
Balance— December 31, 2021
$818 $10,000 
Vesting and remeasurement of SARs, net of exercises(234)— 
Purchases of strategic investments— 5,000 
Amount reclassified from liability to equity upon exchange(62)— 
Unrealized loss on strategic investments— (2,896)
Balance— September 30, 2022
$522 $12,104 
Summary of the Changes in the Fair Value of Level 3 Financial Instruments
A summary of the changes in the fair value of Level 3 financial instruments, of which remeasurement of SARs and impairment of strategic investments are recognized in the condensed consolidated statements of operations, is as follows (in thousands):

Stock Appreciation RightsStrategic Investments
Balance— June 30, 2023
$30 $10,311 
Vesting and remeasurement of SARs(4)— 
Balance— September 30, 2023
$26 $10,311 
Balance— June 30, 2022
$419 $15,000 
Vesting and remeasurement of SARs, net of exercises165 — 
Amount reclassified from liability to equity upon exchange(62)— 
Unrealized loss on strategic investments— (2,896)
Balance— September 30, 2022
$522 $12,104 
Balance— December 31, 2022
$462 $12,104 
Vesting and remeasurement of SARs(183)— 
Exercises of SARs(253)— 
Unrealized loss on strategic investments— (1,793)
Balance— September 30, 2023
$26 $10,311 
Balance— December 31, 2021
$818 $10,000 
Vesting and remeasurement of SARs, net of exercises(234)— 
Purchases of strategic investments— 5,000 
Amount reclassified from liability to equity upon exchange(62)— 
Unrealized loss on strategic investments— (2,896)
Balance— September 30, 2022
$522 $12,104